State Street’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$100M Buy
958,503
+52,483
+6% +$5.48M ﹤0.01% 1314
2025
Q1
$106M Sell
906,020
-41,231
-4% -$4.81M ﹤0.01% 1239
2024
Q4
$80.1M Buy
947,251
+30,443
+3% +$2.58M ﹤0.01% 1477
2024
Q3
$82.4M Sell
916,808
-21,695
-2% -$1.95M ﹤0.01% 1440
2024
Q2
$75.5M Sell
938,503
-213
-0% -$17.1K ﹤0.01% 1441
2024
Q1
$74.9M Buy
938,716
+14,526
+2% +$1.16M ﹤0.01% 1495
2023
Q4
$73.6M Buy
924,190
+56,543
+7% +$4.5M ﹤0.01% 1487
2023
Q3
$60.6M Buy
867,647
+42,458
+5% +$2.97M ﹤0.01% 1500
2023
Q2
$59.3M Buy
825,189
+29,144
+4% +$2.09M ﹤0.01% 1561
2023
Q1
$49.1M Buy
796,045
+39,175
+5% +$2.42M ﹤0.01% 1657
2022
Q4
$58.4M Buy
756,870
+45,538
+6% +$3.51M ﹤0.01% 1522
2022
Q3
$31.7M Sell
711,332
-141,651
-17% -$6.32M ﹤0.01% 1907
2022
Q2
$32.7M Buy
852,983
+153,977
+22% +$5.9M ﹤0.01% 1913
2022
Q1
$28.9M Sell
699,006
-46,901
-6% -$1.94M ﹤0.01% 2133
2021
Q4
$28.2M Sell
745,907
-39,666
-5% -$1.5M ﹤0.01% 2219
2021
Q3
$25.9M Buy
785,573
+145,816
+23% +$4.81M ﹤0.01% 2291
2021
Q2
$43.2M Buy
639,757
+10,589
+2% +$714K ﹤0.01% 1953
2021
Q1
$35.6M Sell
629,168
-14,449
-2% -$818K ﹤0.01% 1986
2020
Q4
$52.4M Sell
643,617
-10,317
-2% -$841K ﹤0.01% 1608
2020
Q3
$46.6M Sell
653,934
-66,792
-9% -$4.76M ﹤0.01% 1519
2020
Q2
$59.3M Buy
720,726
+59,411
+9% +$4.89M ﹤0.01% 1335
2020
Q1
$38.9M Buy
661,315
+31,639
+5% +$1.86M ﹤0.01% 1415
2019
Q4
$65.1M Sell
629,676
-100,006
-14% -$10.3M ﹤0.01% 1343
2019
Q3
$14.8M Buy
729,682
+78,209
+12% +$1.58M ﹤0.01% 2262
2019
Q2
$16.8M Buy
651,473
+637,773
+4,655% +$16.4M ﹤0.01% 2223
2019
Q1
$195K Buy
+13,700
New +$195K ﹤0.01% 3577
2017
Q2
Sell
-138,188
Closed -$540K 3704
2017
Q1
$540K Buy
138,188
+3,500
+3% +$13.7K ﹤0.01% 3371
2016
Q4
$908K Buy
134,688
+8,466
+7% +$57.1K ﹤0.01% 3300
2016
Q3
$996K Buy
126,222
+12,731
+11% +$100K ﹤0.01% 3193
2016
Q2
$856K Buy
+113,491
New +$856K ﹤0.01% 3305